Breaking News

WuXi Biologics Receives Manufacturing License from German Health Authorities

The inspections comprised areas of cGMP manufacturing required for receiving the permit, as well as commercial production approval.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WuXi Biologics has received the License of Manufacturing Permit from German health authorities for its drug product facility (DP7) in Leverkusen, Germany.   The six-day inspection was conducted by five inspectors from the Health Authority of Cologne District Government (Bezirksregierung Köln) and other regional inspectorates. The scope of the inspections comprised areas of cGMP manufacturing required for receiving the permit, as well as commercial production approval. The inspection covered qu...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters